Abstracts for this year’s American Society of Clinical Oncology dropped as usual two weeks ahead of the 29-31 May meeting, but this year the curtain has been raised on a different stage setting: there are fewer abstracts but more complete data released than for previous ASCO conferences.
Pharma Intelligence’s Biomedtracker and Datamonitor Healthcare’s Pre-ASCO Report in 2019 covered over 2,000 poster sessions compared with just over 400...